Strategies to Identify and Manage Immune-Mediated Adverse Events With Immune Checkpoint Inhibitors

In this downloadable slideset, Sandra Cuellar, PharmD, BCOP, reviews pharmacy perspectives in the assessment and management of adverse events associated with immune checkpoint therapy in the care of patients with stage III NSCLC.
Format: Microsoft PowerPoint (.ppt)
File Size: 2.81 MB
Released: April 27, 2018

Acknowledgements

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

This activity is supported by an educational grant from
AstraZeneca

Related Content

Phase II results of poziotinib in patients with heavily pretreated EGFR or HER2 exon 20–mutated NSCLC from WCLC 2018 reported by Clinical Care Options (CCO).

Released: October 2, 2018

Results of ALTER1202 trial show significant PFS benefit with anlotinib for patients with SCLC who progressed after 2 lines of chemotherapy from WCLC 2018 reported by Clinical Care Options (CCO).

Released: October 2, 2018

Entrectinib in ROS1-positive NSCLC showed substantial activity, even in patients with CNS metastases in an analysis of 3 early studies from WCLC 2018 reported by Clinical Care Options (CCO)

Released: October 2, 2018

10-year mortality results from NELSON study in high-risk smokers followed with low-dose CT screening from WCLC 2018 reported by Clinical Care Options (CCO).

Released: October 2, 2018

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?